Third quarter 2021 results


Third quarter 2021 results were reviewed by management during a conference call with the financial community. The presentation was followed by a Q&A session.

The third quarter of 2021 marked an excellent performance for Sanofi, with double digit sales growth and remarkable progress in R&D.

Paul Hudson

Chief Executive Officer


Access the recorded audio webcast


Press release


Q3 2021 Income statements

Q3 2021 net sales by GBU, franchise, geographic region and product

R&D appendix

Download infographic

Memorandum for modelling purposes